Participants 176 314 3
patients of subcutaneous sumatriptan 6 mg, administered using a novel cartridge system self-injector, for the acute treatment of migraine.
Participants 315 430 7
Eighty patients treated all migraine attacks for 6 months at home with a subcutaneous injection of sumatriptan 6 mg
